These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 22017298)
21. Clostridium botulinum neurotoxin type B is heat-stable in milk and not inactivated by pasteurization. Rasooly R; Do PM J Agric Food Chem; 2010 Dec; 58(23):12557-61. PubMed ID: 21053906 [TBL] [Abstract][Full Text] [Related]
22. Implementing the Bruker MALDI Biotyper in the Public Health Laboratory for C. botulinum Neurotoxin Detection. Perry MJ; Centurioni DA; Davis SW; Hannett GE; Musser KA; Egan CT Toxins (Basel); 2017 Mar; 9(3):. PubMed ID: 28282915 [TBL] [Abstract][Full Text] [Related]
23. Optimization of peptide substrates for botulinum neurotoxin E improves detection sensitivity in the Endopep-MS assay. Wang D; Krilich J; Baudys J; Barr JR; Kalb SR Anal Biochem; 2015 Jan; 468():15-21. PubMed ID: 25232998 [TBL] [Abstract][Full Text] [Related]
24. Proposed BoNT/A and /B Peptide Substrates Cannot Detect Multiple Subtypes in the Endopep-MS Assay. Kalb SR; Baudys J; Kiernan K; Wang D; Becher F; Barr JR J Anal Toxicol; 2020 Mar; 44(2):173-179. PubMed ID: 31287544 [TBL] [Abstract][Full Text] [Related]
25. A two-stage multiplex method for quantitative analysis of botulinum neurotoxins type A, B, E, and F by MALDI-TOF mass spectrometry. Wang D; Baudys J; Krilich J; Smith TJ; Barr JR; Kalb SR Anal Chem; 2014 Nov; 86(21):10847-54. PubMed ID: 25285509 [TBL] [Abstract][Full Text] [Related]
26. Studies on botulinum neurotoxins type /C1 and mosaic/DC using Endopep-MS and proteomics. Moura H; Terilli RR; Woolfitt AR; Gallegos-Candela M; McWilliams LG; Solano MI; Pirkle JL; Barr JR FEMS Immunol Med Microbiol; 2011 Apr; 61(3):288-300. PubMed ID: 21205003 [TBL] [Abstract][Full Text] [Related]
27. Monoclonal Antibody Combinations Prevent Serotype A and Serotype B Inhalational Botulism in a Guinea Pig Model. Tomic MT; Espinoza Y; Martinez Z; Pham K; Cobb RR; Snow DM; Earnhart CG; Pals T; Syar ES; Niemuth N; Kobs DJ; Farr-Jones S; Marks JD Toxins (Basel); 2019 Apr; 11(4):. PubMed ID: 30959899 [TBL] [Abstract][Full Text] [Related]
28. Use of Monoclonal Antibodies in the Sensitive Detection and Neutralization of Botulinum Neurotoxin Serotype B. Cheng LW; Henderson TD; Lam TI; Stanker LH Toxins (Basel); 2015 Nov; 7(12):5068-78. PubMed ID: 26633496 [TBL] [Abstract][Full Text] [Related]
29. An assay for botulinum toxin types A, B and F that requires both functional binding and catalytic activities within the neurotoxin. Evans ER; Skipper PJ; Shone CC J Appl Microbiol; 2009 Oct; 107(4):1384-91. PubMed ID: 19426271 [TBL] [Abstract][Full Text] [Related]
30. Development of a multiplex Endopep-MS assay for simultaneous detection of botulinum toxins A, B and E. Rosen O; Feldberg L; Yamin TS; Dor E; Barnea A; Weissberg A; Zichel R Sci Rep; 2017 Nov; 7(1):14859. PubMed ID: 29093524 [TBL] [Abstract][Full Text] [Related]
31. A Monoclonal Antibody Combination against both Serotypes A and B Botulinum Toxin Prevents Inhalational Botulism in a Guinea Pig Model. Snow DM; Cobb RR; Martinez J; Finger-Baker I; Collins L; Terpening S; Syar ES; Niemuth N; Kobs D; Barnewall R; Farr-Jones S; Marks JD; Tomic MT Toxins (Basel); 2021 Jan; 13(1):. PubMed ID: 33466411 [TBL] [Abstract][Full Text] [Related]
32. Rapid and selective detection of botulinum neurotoxin serotype-A and -B with a single immunochromatographic test strip. Ching KH; Lin A; McGarvey JA; Stanker LH; Hnasko R J Immunol Methods; 2012 Jun; 380(1-2):23-9. PubMed ID: 22504369 [TBL] [Abstract][Full Text] [Related]
33. Extraction and inhibition of enzymatic activity of botulinum neurotoxins /B1, /B2, /B3, /B4, and /B5 by a panel of monoclonal anti-BoNT/B antibodies. Kalb SR; Santana WI; Geren IN; Garcia-Rodriguez C; Lou J; Smith TJ; Marks JD; Smith LA; Pirkle JL; Barr JR BMC Biochem; 2011 Nov; 12():58. PubMed ID: 22085466 [TBL] [Abstract][Full Text] [Related]
34. Botulinum neurotoxin serotype D attacks neurons via two carbohydrate-binding sites in a ganglioside-dependent manner. Strotmeier J; Lee K; Völker AK; Mahrhold S; Zong Y; Zeiser J; Zhou J; Pich A; Bigalke H; Binz T; Rummel A; Jin R Biochem J; 2010 Oct; 431(2):207-16. PubMed ID: 20704566 [TBL] [Abstract][Full Text] [Related]
35. Molecular immune recognition of botulinum neurotoxin B. The light chain regions that bind human blocking antibodies from toxin-treated cervical dystonia patients. Antigenic structure of the entire BoNT/B molecule. Atassi MZ; Jankovic J; Steward LE; Aoki KR; Dolimbek BZ Immunobiology; 2012 Jan; 217(1):17-27. PubMed ID: 21962573 [TBL] [Abstract][Full Text] [Related]
36. Detection and Quantification of Biologically Active Botulinum Neurotoxin Serotypes A and B Using a Förster Resonance Energy Transfer-Based Quantum Dot Nanobiosensor. Wang Y; Fry HC; Skinner GE; Schill KM; Duncan TV ACS Appl Mater Interfaces; 2017 Sep; 9(37):31446-31457. PubMed ID: 28840718 [TBL] [Abstract][Full Text] [Related]
37. An optical biosensor assay for rapid dual detection of Botulinum neurotoxins A and E. Lévêque C; Ferracci G; Maulet Y; Mazuet C; Popoff MR; Blanchard MP; Seagar M; El Far O Sci Rep; 2015 Dec; 5():17953. PubMed ID: 26648139 [TBL] [Abstract][Full Text] [Related]
38. Sensitive detection of type G botulinum neurotoxin through Endopep-MS peptide substrate optimization. Wang D; Baudys J; Hoyt K; Barr JR; Kalb SR Anal Bioanal Chem; 2019 Aug; 411(21):5489-5497. PubMed ID: 31172236 [TBL] [Abstract][Full Text] [Related]
39. Validation of the Endopep-MS method for qualitative detection of active botulinum neurotoxins in human and chicken serum. Björnstad K; Tevell Åberg A; Kalb SR; Wang D; Barr JR; Bondesson U; Hedeland M Anal Bioanal Chem; 2014 Nov; 406(28):7149-61. PubMed ID: 25228079 [TBL] [Abstract][Full Text] [Related]